The Primark Meketa Private Equity Investments Fund (Ticker: PMPEX) is a continuously offered closed-end interval fund, registered under the Investment Company Act of 1940. The Fund is designed to provide exposure primarily to the middle market segment of the private equity asset class and aims to provide recurring revenue, positive cash flow and diversification across geography, industry, vintage year, and portfolio management.
* Co-investments typically limit the amount of control management has over the assets within the portfolio and the timing of certain actions. There can be conflicts of interest between the two co-investing parties.
* SEC registered does not imply endorsement or any other special features. The majority of public funds are SEC registered.
America’s middle market companies – those typically viewed as having annual revenues between $10 million and $1 billion – make up more than 30% of the U.S. economy, but because most are privately owned, individual investors may miss out on opportunities to invest.
Through Meketa’s specialized teams and processes built over the past 20 years, we are able to rigorously evaluate hundreds of investments across the full range of private market opportunities and render unique perspectives in an effort to generate top-quartile returns.
*Year-End 2022 Middle Market Indicator. National Center for the Middle Market. 2023.
accessiBe is a provider of software that automates compliance standards for its customers and agency partners, making web content and websites accessible for people with disabilities.
Apotex is a global pharmaceutical company that produces high-quality, affordable medicines for patients around the world.
A cloud-based cyber defense platform that directly integrates into clients’ operations to use data, machine learning and automation to reduce companies’ risks of cyber threats.
accessiBe is a provider of software that automates compliance standards for its customers and agency partners, making web content and websites accessible for people with disabilities.
Apotex is a global pharmaceutical company that produces high-quality, affordable medicines for patients around the world.
A cloud-based cyber defense platform that directly integrates into clients’ operations to use data, machine learning and automation to reduce companies’ risks of cyber threats.
accessiBe is a provider of software that automates compliance standards for its customers and agency partners, making web content and websites accessible for people with disabilities.
Apotex is a global pharmaceutical company that produces high-quality, affordable medicines for patients around the world.
A cloud-based cyber defense platform that directly integrates into clients’ operations to use data, machine learning and automation to reduce companies’ risks of cyber threats.
IMPORTANT INFORMATION
Investors should carefully consider the Fund’s investment objectives, risks, charges, and expenses before investing. This information is included in, and may be reviewed through the prospectus. Please read the prospectus carefully. An investment in the Fund is subject to, among others, the following risks:
The Fund is considered highly speculative, illiquid, and should only be considered by investors who can bear such risk for an indefinite period of time and can afford a complete loss of investment. There is no guarantee that any income will be generated, or distributions will be made. The shares are illiquid meaning you will likely not be able to transfer or redeem shares on demand or in the quantity desired. An investment will involve significant risks due to the nature of the fund’s investments. The fund does not represent a complete investment portfolio. There can be no assurance that the investment objectives of the Fund will be achieved. The managers and portfolio structure provided herein may be subject to change.
The Fund is not intended as a complete investment program but rather the Fund is designed to help investors diversify into private equity investments.
The Fund is a “nondiversified” management investment company registered under the Investment Company Act of 1940. An investment in the Fund involves risk.
The Fund is new with no significant operating history by which to evaluate its potential performance. There can be no assurance that the Fund’s strategy will be successful.
Shares of the Fund are not listed on any securities exchange and it is not anticipated that a secondary market for shares will develop. Shares are appropriate only for those investors who can tolerate a high degree of risk, do not require a liquid investment.
There is no assurance that you will be able to tender your shares when or in the amount that you desire. Although the Fund will offer quarterly liquidity through a quarterly repurchase process, an investor may not be able to sell or otherwise liquidate all their shares tendered during a quarterly repurchase offer.
The Fund’s investment in private equity companies is speculative and involves a high degree of risk, including the risk associated with leverage.
Distributor: Foreside Financial Services, LLC. Member FINRA. Foreside is not affiliated with the closed end fund or any of the entities named within this communication.
MCL-506919-2024-02-29